tiprankstipranks
Advertisement
Advertisement

JP:4883 Stock Latest News

Modalis Highlights CRISPR-GNDM Platform as Cornerstone of Rare Disease Growth Strategy
Company AnnouncementsModalis Highlights CRISPR-GNDM Platform as Cornerstone of Rare Disease Growth Strategy
14d ago
4883
Modalis Books ¥14 Million in FX Gains, Boosting Quarterly Results
PremiumCompany Announcements
Modalis Books ¥14 Million in FX Gains, Boosting Quarterly Results
3M ago
4883
Modalis outlines conditions and limitations around its Q1 2026 disclosure
PremiumCompany Announcements
Modalis outlines conditions and limitations around its Q1 2026 disclosure
3M ago
4883
Modalis Narrows Quarterly Loss but Keeps Outlook Uncertain Amid Zero Revenue
PremiumCompany Announcements
Modalis Narrows Quarterly Loss but Keeps Outlook Uncertain Amid Zero Revenue
3M ago
4883
Modalis Sells Idle U.S. Equipment, Books Extraordinary Gain on Asset Transfer
PremiumCompany Announcements
Modalis Sells Idle U.S. Equipment, Books Extraordinary Gain on Asset Transfer
3M ago
4883
Modalis Sets Terms for 18th Stock Option Plan, Issuing 935,000 Potential Shares
PremiumCompany AnnouncementsModalis Sets Terms for 18th Stock Option Plan, Issuing 935,000 Potential Shares
3M ago
4883
Modalis Therapeutics Issues 18th Series Stock Options to Align Incentives and Retain Talent
Premium
Company Announcements
Modalis Therapeutics Issues 18th Series Stock Options to Align Incentives and Retain Talent
4M ago
4883
Modalis Outlines FY2025 Growth Plans in Confidential TSE-Mandated Update
Premium
Company Announcements
Modalis Outlines FY2025 Growth Plans in Confidential TSE-Mandated Update
4M ago
4883
Modalis Therapeutics Seeks Approval for Virtual-Ready Shareholder Meetings
PremiumCompany Announcements
Modalis Therapeutics Seeks Approval for Virtual-Ready Shareholder Meetings
5M ago
4883
Modalis to Wipe Out Retained Earnings Deficit via Capital Reduction
PremiumCompany Announcements
Modalis to Wipe Out Retained Earnings Deficit via Capital Reduction
5M ago
4883
Modalis Slows IND Timeline for Lead CRISPR Program as It Strengthens Clinical Readiness
PremiumCompany Announcements
Modalis Slows IND Timeline for Lead CRISPR Program as It Strengthens Clinical Readiness
6M ago
4883
Modalis Loss Widens on Higher R&D Spend Amid Zero Revenue in FY2025
PremiumCompany Announcements
Modalis Loss Widens on Higher R&D Spend Amid Zero Revenue in FY2025
6M ago
4883
Modalis Books Foreign Exchange Gain for FY2025 on Currency Revaluation
PremiumCompany AnnouncementsModalis Books Foreign Exchange Gain for FY2025 on Currency Revaluation
6M ago
4883
Modalis Issues FY2025 Report With Strict Confidentiality and Risk Disclaimers
Premium
Company Announcements
Modalis Issues FY2025 Report With Strict Confidentiality and Risk Disclaimers
6M ago
4883
Modalis posts wider losses in 2025, with no revenue and no 2026 guidance
Premium
Company Announcements
Modalis posts wider losses in 2025, with no revenue and no 2026 guidance
6M ago
4883
Modalis Therapeutics Issues New Shares for Employee Incentive Plan
PremiumCompany Announcements
Modalis Therapeutics Issues New Shares for Employee Incentive Plan
9M ago
4883
Modalis Therapeutics Reports Foreign Exchange Loss
PremiumCompany Announcements
Modalis Therapeutics Reports Foreign Exchange Loss
9M ago
4883
Modalis Therapeutics Reports Increased Losses and Decline in Financial Position
PremiumCompany Announcements
Modalis Therapeutics Reports Increased Losses and Decline in Financial Position
9M ago
4883
Modalis Therapeutics Announces Key Executive Appointments
PremiumCompany Announcements
Modalis Therapeutics Announces Key Executive Appointments
10M ago
4883
Modalis Therapeutics Reports Foreign Exchange Loss Impacting Earnings
PremiumCompany AnnouncementsModalis Therapeutics Reports Foreign Exchange Loss Impacting Earnings
12M ago
4883
Modalis Therapeutics Reports Financial Results for H1 2025
Premium
Company Announcements
Modalis Therapeutics Reports Financial Results for H1 2025
12M ago
4883
Modalis Therapeutics Issues New Shares for Employee Compensation
Premium
Company Announcements
Modalis Therapeutics Issues New Shares for Employee Compensation
1y ago
4883

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >